Analysis: New variant XBB.1.5 is ‘most transmissible’ yet, could fuel covid wave

Omicron COVID booster cuts hospitalization in over 65s -- Israeli study

New studies outline Omicron immune protection after infection, vaccination

A pair of new studies describe infection- and vaccine-conferred immunity against the SARS-CoV-2 Omicron variant, with one showing that vaccinated people have good protection against BA.5 subvariant reinfection for at least 8 months after infection, and the other finding that the vaccine is 46% and 70% effective against infection and hospitalization, respectively, in children.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Why there are so many COVID-19 cases, hospitalizations in the Northeast and what we know about it

China’s Covid wave threatens delays in U.S. and other medical supply chains

CDC revises figures, says Omicron subvariant XBB.1.5 accounts for 27.6% of U.S. COVID cases

People who haven't had COVID will likely catch the new XBB.1.5 variant, experts say

CureVac says COVID vaccine produced immune response in early-stage trial

China is not reporting true impact of Covid outbreak, WHO says

The Symptoms Of COVID Variant XBB seen so far

...

Because XBB is relatively new, scientists are still working to figure out if and how the variant behaves differently from other recent variants. Though XBB’s symptoms are expected to be on par with past omicron infections, doctors say they are seeing some issues becoming more prevalent than others.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

NIH launches pilot telehealth program to help treat COVID

Florida surgeon general used ‘flawed’ science to discourage vaccinations -- university faculty peers

Uganda's Ebola outbreak is coming under control -- Africa CDC

Some school districts bring back mask mandates to stem spread of COVID, flu and RSV

Even mild Covid cases can lead to long prpblems--new study

Pages

Subscribe to Global RSS
howdy folks
Page loaded in 0.884 seconds.